We demonstrated that aberrantly down‐regulated miR‐449b‐3p targeted ADAM17 to promote NPC metastasis, and ADAM17‐activated NF‐κB could transcriptionally suppress miR‐449b‐3p gene expression in turn. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.